
Loading, please wait...

Loading, please wait...

PAX5 rearrangements (PAX5-r) act as a critical genetic driver in B-cell acute lymphoblastic leukaemia. Recent research has identified a novel in-frame PAX5 fusion in B-ALL, involving the GSE1 gene. This discovery provides fresh insights into the molecular landscape of the disease. Furthermore, it highlights new opportunities for monitoring treatment response through specialized biomarkers.
The PAX5::GSE1 fusion protein localizes directly to the cell nucleus. Once there, it actively promotes cell proliferation while suppressing the transcriptional activity of wild-type PAX5. Because of this, the fusion gene effectively disrupts normal B-cell development. Researchers also found that transcript levels of this fusion correlate significantly with treatment response. Consequently, this makes it a promising biomarker for minimal residual disease (MRD) monitoring.
An analysis of 330 patients with PAX5-r B-ALL revealed 76 distinct in-frame partner genes. Although these partners vary, they induce a convergent expression profile. This profile is characterized by the dysregulation of the retinoblastoma transcriptional corepressor 1 (RB1) and p53 pathways. Additionally, many cases show a marked overexpression of nucleophosmin 1 (NPM1). These findings help clarify the core mechanisms of leukaemogenesis. Ultimately, they point toward potential therapeutic vulnerabilities in patients carrying these genetic signatures.
The PAX5::GSE1 fusion promotes leukemia cell growth and serves as a potential biomarker for monitoring minimal residual disease (MRD) and treatment response.
It creates a convergent profile featuring p53 and RB1 pathway dysregulation along with the overexpression of nucleophosmin 1 (NPM1).
In a large-scale study of 330 patients, researchers identified 76 distinct in-frame partner genes that fuse with PAX5.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Wang H et al. Identification of GSE1 as a PAX5 fusion partner and characterization of PAX5 fusion signature in B-cell acute lymphoblastic leukaemia. Br J Haematol. 2026 May 27. doi: 10.1111/bjh.70578. PMID: 42204379.
2. Gu Z, Johnstone AL, Schore RJ, et al. PAX5 alterations in B-cell acute lymphoblastic leukemia. Front Oncol. 2022 Oct 25;12:1010375. doi: 10.3389/fonc.2022.1010375.
3. Liu Y et al. Recurrent PAX5::ZCCHC7 rearrangement in B-cell acute lymphoblastic leukemia. Ann Hematol. 2024 Dec;103(12):5599-5605. doi: 10.1007/s00277-024-06114-y.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers have identified GSE1 as a novel PAX5 fusion partner in B-cell acute lymphoblastic leukaemia, offering new insights into MRD monitoring....
last month

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today